About Drupal 8
Have you ever felt that your website needs to be more personalized, integrated with cutting-edge technology to offer enhanced user experience?
Valuebound is one of those companies, which specifically help organizations in their path to digital transformation. We enhance digital experience for end users with tailored web applications.
Recent releases
|
Digital Twins in Life Sciences: Use Cases Explained
Life sciences is in the middle of a technology shift. Traditional R&D models are expensive, slow, and full of risks. Clinical trials stall. Manufacturing costs rise. Patient outcomes don’t…
|
How to Do Personalized Healthcare Marketing with Patient Data
Healthcare marketing has changed forever. Patients expect more than generic campaigns. They want relevance, accuracy, and continuity. Doctors expect interactions that respect their time and deliver…
|
Pharma Martech Stack 2025: CMO Checklist for Growth
The pharmaceutical industry has entered a new marketing era. Reps alone can’t carry the message. Patients expect digital continuity. Regulators demand compliance at every step. And CMOs are expected…
|
CMO's Guide to Pharma Compliance with MLR Automation
Pharma compliance in India is no longer just about staying out of trouble. It’s about protecting credibility, accelerating time-to-market, and ensuring every campaign you launch stands up to…
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
